|
Name |
Austin
|
Molecular Formula | C27H32O9 | |
IUPAC Name* |
[(1S,2R,5S,8R,9R,12S,13S)-12-hydroxy-2,2',2',6,9,13-hexamethyl-16-methylidene-6',11,15-trioxospiro[10,14-dioxatetracyclo[7.6.1.01,12.02,7]hexadec-6-ene-5,3'-pyran]-8-yl] acetate
|
|
SMILES |
C[C@H]1[C@@]2(C(=O)O[C@]3([C@@H](C4=C([C@]5(CC[C@]4([C@@]2(C3=C)C(=O)O1)C)C=CC(=O)OC5(C)C)C)OC(=O)C)C)O
|
|
InChI |
InChI=1S/C27H32O9/c1-13-18-19(34-16(4)28)24(8)14(2)26(20(30)33-15(3)27(26,32)21(31)36-24)23(18,7)11-12-25(13)10-9-17(29)35-22(25,5)6/h9-10,15,19,32H,2,11-12H2,1,3-8H3/t15-,19+,23+,24+,25+,26+,27-/m0/s1
|
|
InChIKey |
DEMDOYQPCDXCEB-WLEVADLXSA-N
|
|
Synonyms |
Austin; 61103-89-7; TTT25XE98E; NSC-280416; UNII-TTT25XE98E; DTXSID00893994; NSC 280416; Q27290349; (3S-(3.ALPHA.,3A.ALPHA.,6.BETA.,7.BETA.,9.BETA.,11A.BETA.,11B.BETA.))-7-(ACETYLOXY)-3,3A,6,7,11,11A-HEXAHYDRO-3A-HYDROXY-2',2',3,6,8,11A-HEXAMETHYL-12-METHYLENESPIRO(1H-6,11B-METHANO-4H-FURO(3,4-E)(3)BENZOXOCIN-9(10H),3'(6'H)-(2H)PYRAN)-1,4,6'-TRIONE; SPIRO(1H-6,11B-METHANO-4H-FURO(3,4-E)(3)BENZOXOCIN-9(10H),3'(6'H)-(2H)PYRAN)-1,4,6'-TRIONE, 7-(ACETYLOXY)-3,3A,6,7,11,11A-HEXAHYDRO-3A-HYDROXY-2',2',3,6,8,11A-HEXAMETHYL-12-METHYLENE-, (3S,3'S,3AS,6R,7R,11AR,11BS)-; SPIRO(3AH-6,11B-METHANO-3H-BENZO(E)FURO(3,4-C)OXOCIN-9(10H),3'(6'H)-(2H)PYRAN)-1,4,6'-TRIONE, 7-(ACETYLOXY)-6,7,11,11A-TETRAHYDRO-3A-HYDROXY-2',2',3,6,8,11A-HEXAMETHYL-12-METHYLENE-, (3S,3'S,3AS,6R,7R,11AR,11BS)-
|
|
CAS | 61103-89-7 | |
PubChem CID | 38353601 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 500.5 | ALogp: | 1.4 |
HBD: | 1 | HBA: | 9 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 125.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 36 | QED Weighted: | 0.328 |
Caco-2 Permeability: | -5.419 | MDCK Permeability: | 0.00005010 |
Pgp-inhibitor: | 0.836 | Pgp-substrate: | 0.117 |
Human Intestinal Absorption (HIA): | 0.251 | 20% Bioavailability (F20%): | 0.986 |
30% Bioavailability (F30%): | 0.902 |
Blood-Brain-Barrier Penetration (BBB): | 0.893 | Plasma Protein Binding (PPB): | 75.81% |
Volume Distribution (VD): | 1.38 | Fu: | 27.04% |
CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.93 |
CYP2C19-inhibitor: | 0.176 | CYP2C19-substrate: | 0.622 |
CYP2C9-inhibitor: | 0.087 | CYP2C9-substrate: | 0.012 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.012 |
CYP3A4-inhibitor: | 0.735 | CYP3A4-substrate: | 0.895 |
Clearance (CL): | 2.48 | Half-life (T1/2): | 0.131 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.937 |
Drug-inuced Liver Injury (DILI): | 0.886 | AMES Toxicity: | 0.967 |
Rat Oral Acute Toxicity: | 0.584 | Maximum Recommended Daily Dose: | 0.483 |
Skin Sensitization: | 0.428 | Carcinogencity: | 0.967 |
Eye Corrosion: | 0.137 | Eye Irritation: | 0.101 |
Respiratory Toxicity: | 0.931 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005188 | 0.833 | D0H2MO | 0.242 | ||||
ENC005318 | 0.833 | D03ZZK | 0.235 | ||||
ENC002987 | 0.802 | D0K7LU | 0.231 | ||||
ENC005189 | 0.639 | D0KR9U | 0.227 | ||||
ENC005317 | 0.639 | D0E9KA | 0.221 | ||||
ENC003309 | 0.619 | D09WYX | 0.220 | ||||
ENC005315 | 0.569 | D0P0HT | 0.219 | ||||
ENC002849 | 0.551 | D0X4RS | 0.217 | ||||
ENC003179 | 0.534 | D04GJN | 0.216 | ||||
ENC005316 | 0.534 | D0N0RU | 0.213 |